SINGAPORE, June 30, 2022 – PartnerRe is pleased to announce today the appointment of Shin Yagisawa as Chief Representative Officer of PartnerRe’s Life and Health Representative Office in Tokyo, Japan, effective July 1, 2022.
Yagisawa joins Yuji Ueno, Head Representative Financial Solutions, in PartnerRe’s Tokyo office, supported by the broader PartnerRe Life & Health APAC team based in Hong Kong and Singapore as well as the international expertise of the PartnerRe Group.
Shin Yagisawa has more than 25 years combined experience in the insurance and banking industries, primarily in marketing and distribution. Yagisawa-san’s most recent role was Chief Marketing Officer at RGA Japan Branch where he led a team of business developers in delivering a broad range of solutions to life insurers.
Commenting on Yagisawa’s appointment, PartnerRe’s CEO of Life & Health APAC, John Mok said, “Our representative office in Japan underlines our commitment to providing relevant and impactful Life & Health solutions to our clients in Japan. Yagisawa will help us to further deepen our client relationships in this important market.”
Yagisawa graduated from Gakushuin University with a degree in law and holds an MBA from Durham University Business School.
_____________________________________________
About PartnerRe
PartnerRe Ltd. is a leading global reinsurer that helps insurance companies reduce their earnings volatility, strengthen their capital and grow their businesses through reinsurance solutions. Risks are underwritten on a worldwide basis through the Company’s three segments: P&C, Specialty, and Life and Health. For the year ended December 31, 2021, total revenues were $7.4 billion. At March 31, 2022, total assets were $28.4 billion, total capital was $8.7 billion and total shareholders’ equity was $6.8 billion. PartnerRe maintains strong financial strength ratings as follows: A.M. Best A+ / Moody’s A1 / Standard & Poor’s A+.
PartnerRe on the Internet: www.partnerre.com
| Contacts: | PartnerRe Ltd. |
| (441) 292-0888 | |
| Media Contact: Celia Powell Investor Contact: Ryan Lipschutz |
